Delivery Order 75N95022D00021-75N95023F00002

Award Date 6/16/23
Potential Completion Date 6/15/28
Potential Value $495K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Columbus, OH 43201, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Battelle Memorial Institute, doing business as Battelle, has been awarded an $11,476 delivery order against the Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke's Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders indefinite-delivery/indefinite-quantity multiple award contract. The delivery order is for a contract kickoff meeting and...
This is a delivery order awarded to Battelle Memorial Institute by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), under a $149 million master indefinite-delivery indefinite-quantity (IDIQ) contract for manufacturing and nonclinical studies of neurological therapeutic biotechnology products. The $2,187,611 delivery order is for the development of enzyme-linked immunosorbent assays (ELISAs) in support of NINDS' Blueprint...
This is a $14,106,772 cost plus fixed fee delivery order awarded by the National Center for Advancing Translational Sciences, a civilian agency, to Battelle Memorial Institute for validation of bioanalytical assays and IND-enabling GLP PD/PK toxicology studies in rats and dogs. The work is being performed under the Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders indefinite delivery, indefinite quantity...
This is a delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the U.S. Department of Health and Human Services, to Battelle Memorial Institute, a nonprofit research and development organization. The $11,168,464 contract is for the manufacturing of plasmid and vector, as well as good laboratory practice (GLP) dose-escalation toxicology studies in normal rats and non-human primates. This delivery order is part of a larger...
This is a federal contract award to Battelle Memorial Institute (doing business as Battelle), a non-profit research and development organization, by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS). The contract, valued at $460,936.39, is for non-clinical safety assessment of the compound JM-4 to support multiple sclerosis and traumatic brain injury indications. The contract is a delivery order...
The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $4,288 delivery order to Battelle Memorial Institute under the Center's master IDIQ contract for CRO Support for in vitro and in vivo toxicology studies. Under the order, Battelle will perform non-clinical safety assessment of CTI-1601 to support an ataxia indication as requested by the Center. The work will be conducted in Columbus, Ohio over an 18-month period concluding in March 2019. Funding...
This is a definitive contract valued at $69,611,517.00 awarded by the National Institutes of Health (NIH) to Battelle Memorial Institute, a nonprofit organization and manufacturer of goods, to conduct studies evaluating the toxicologic and carcinogenic potential of various substances. The contract does not have a set-aside designation. Battelle frequently partners with specialized manufacturers and technical consultants to deliver a wide range of research, engineering, testing, and information...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1.6 million cost-plus-fixed-fee delivery order contract to Battelle Memorial Institute. The prime contractor will provide research and development services for biomedical and applied exploratory development related to evaluation and testing of vaccines and other biologics for infectious diseases. Two subcontractors, the University of Texas Medical Branch at...
This is a delivery order issued against a larger contract vehicle by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The $435,767.78 award to Battelle Memorial Institute, a non-profit research and development organization, covers clinical and non-human primate sample testing for SARS-CoV-2 vaccine and other biological product candidates. The delivery order does not have a set-aside designation. Battelle...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Battelle Memorial Institute, a large nonprofit research and development organization. The contract is for the "Evaluation of Clinical Samples from Influenza Clinical Trials" and has a ceiling value of $5,744,120.00. The contract is a Delivery Order under the NIAID's existing contract vehicle, with a Cost Plus Fixed Fee pricing structure. The contract...

Battelle Memorial Institute has been awarded a delivery order against the Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders indefinite-delivery/indefinite-quantity (IDIQ) contract by the National Institutes of Health's National Institute of Neurological Disorders and Stroke. The $494,704 delivery order is for liquid chromatography with tandem mass spectrometry (HPLC-MS-MS) assay validation and sample testing services to support the agency's research efforts. The work will be performed in Columbus, Ohio through June 15, 2028. No set-aside provisions were applied to this award made to the nonprofit research organization.

Generated 1/26/24, 10:24 AM